<DOC>
	<DOCNO>NCT01298960</DOCNO>
	<brief_summary>Experimental study evaluate rGH addition standard control ovarian stimulation treatment improve ovarian response woman previous poor ovarian response .</brief_summary>
	<brief_title>Growth Hormone ( GH ) Vitro Fertilization ( IVF ) Poor-responder Patients</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<criteria>Women desire pregnancy regular spontaneous menstrual cycle 2530 day length . Infertility require IVF without ICSI . Antecedent fail previous IVF cycle GnRH long agonist protocol least 3000 IU FSH use ( cancellation due poor ovarian response &lt; 4 mature follicle less 5 oocyte retrieve ) antral follicle count &lt; 5 . Partner sperm . Presence ovaries normal uterine cavity . PAP smear within normality previous 3 year . Negative pregnancy test ( serum urine ) rFSH administration . Willingness adhesion protocol whole study period . Signed informed consent give . HIV , HCV , HBV positive serology woman partner . Important systemic disease could interfere gonadotrophin treatment ( ovarian hypothalamic tumor ... ) . BMI &gt; 32 kg/m2 antecedent diabetes mellitus . Gonadotrophin treatment within previous 30 day . Availability frozen embryos previous IVF cycle . Abnormal uterine bleeding . Previous treatment LH LH effect drug . Polycystic ovary , increase size ovary presence ovarian cyst unknown ethiology . Contraindication pregnancy . Allergies gonadotrophins somatotropin . History drug alcohol abuse previous 5 year . Previous enrollment study simultaneous participation another study drug .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Poor Ovarian response IVF</keyword>
	<keyword>Metaphase II oocyte</keyword>
	<keyword>Pregnancy Rate</keyword>
	<keyword>Growth Hormone</keyword>
</DOC>